Meta-analysis: Aspirin has Potential Benefits for Primary Prevention of Cardiovascular Outcomes in Diabetes

Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials – Cardiovascular Diabetology (free)

Commentary: Aspirin offers benefit for primary CVD prevention in DM – Univadis (free registration required)

Related Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes (free study and commentaries)